148 related articles for article (PubMed ID: 31521528)
1. Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy.
Navarro-Martínez R; Serrano-Carrascosa M; Buigues C; Fernández-Garrido J; Sánchez-Martínez V; Castelló-Domenech AB; García-Villodre L; Wong-Gutiérrez A; Rubio-Briones J; Cauli O
Urol Oncol; 2019 Dec; 37(12):976-987. PubMed ID: 31521528
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen Therapy.
Buigues C; Navarro-Martínez R; Sánchez-Martínez V; Serrano-Carrascosa M; Rubio-Briones J; Cauli O
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610428
[TBL] [Abstract][Full Text] [Related]
3. Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy.
Mafla-España MA; Torregrosa MD; Beamud-Cortés M; Bermell-Marco L; Rubio-Briones J; Cauli O
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002324
[TBL] [Abstract][Full Text] [Related]
4. Re: Frailty Syndrome is Associated with Changes in Peripheral Inflammatory Markers in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.
Griebling TL
J Urol; 2020 Nov; 204(5):1075. PubMed ID: 32845187
[No Abstract] [Full Text] [Related]
5. Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings.
Hoogland AI; Jim HSL; Gonzalez BD; Small BJ; Gilvary D; Breen EC; Bower JE; Fishman M; Zachariah B; Jacobsen PB
Cancer; 2021 May; 127(9):1476-1482. PubMed ID: 33378113
[TBL] [Abstract][Full Text] [Related]
6. Frailty in Older Adults Is Associated With Plasma Concentrations of Inflammatory Mediators but Not With Lymphocyte Subpopulations.
Marcos-Pérez D; Sánchez-Flores M; Maseda A; Lorenzo-López L; Millán-Calenti JC; Gostner JM; Fuchs D; Pásaro E; Laffon B; Valdiglesias V
Front Immunol; 2018; 9():1056. PubMed ID: 29868017
[TBL] [Abstract][Full Text] [Related]
7. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.
Bylow K; Mohile SG; Stadler WM; Dale W
Cancer; 2007 Dec; 110(12):2604-13. PubMed ID: 17960609
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pro-inflammatory cytokines in frail Tunisian older adults.
Hammami S; Ghzaiel I; Hammouda S; Sakly N; Hammami M; Zarrouk A
PLoS One; 2020; 15(11):e0242152. PubMed ID: 33166358
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Frailty Criteria, Cognitive Function, Depressive and Insomnia Symptoms in Men with Localized and Advanced Prostate Cancer under Androgen Deprivation Therapy.
Mafla-España MA; Torregrosa MD; Beamud-Cortés M; Bermell-Marco L; Rubio-Briones J; Cauli O
Healthcare (Basel); 2023 Apr; 11(9):. PubMed ID: 37174808
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
11. Persisting adverse body composition changes 2 years after cessation of androgen deprivation therapy for localised prostate cancer.
Cheung AS; Tinson AJ; Milevski SV; Hoermann R; Zajac JD; Grossmann M
Eur J Endocrinol; 2018 Jul; 179(1):21-29. PubMed ID: 29712718
[TBL] [Abstract][Full Text] [Related]
12. Higher levels of tumor necrosis factor β are associated with frailty in socially vulnerable community-dwelling older adults.
Nascimento CMC; Zazzetta MS; Gomes GAO; Orlandi FS; Gramani-Say K; Vasilceac FA; Gratão ACM; Pavarini SCI; Cominetti MR
BMC Geriatr; 2018 Nov; 18(1):268. PubMed ID: 30400833
[TBL] [Abstract][Full Text] [Related]
13. Effects of androgen deprivation therapy on elderly men with high-risk prostate cancer: PROSARC observational study.
Legido-Gómez Ó; Rico-Marco S; Lorenzo-Sánchez MV; Navarro-Jiménez S; Tárraga-Honrubia MA; Martínez-Ruiz J; Giménez-Bachs JM; Donate-Moreno MJ; Díaz de Mera-Sánchez-Migallón I; Segura-Martín M; Alcantud-Córcoles R; Abizanda-Soler P; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2024 May; 48(4):304-310. PubMed ID: 38373481
[TBL] [Abstract][Full Text] [Related]
14. Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy.
Winters-Stone KM; Moe E; Graff JN; Dieckmann NF; Stoyles S; Borsch C; Alumkal JJ; Amling CL; Beer TM
J Am Geriatr Soc; 2017 Jul; 65(7):1414-1419. PubMed ID: 28263373
[TBL] [Abstract][Full Text] [Related]
15. Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer.
Cheung AS; Hoermann R; Dupuis P; Joon DL; Zajac JD; Grossmann M
Eur J Endocrinol; 2016 Sep; 175(3):229-37. PubMed ID: 27340081
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.
Gonzalez BD; Small BJ; Cases MG; Williams NL; Fishman MN; Jacobsen PB; Jim HSL
Cancer; 2018 Feb; 124(3):499-506. PubMed ID: 29072790
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
[TBL] [Abstract][Full Text] [Related]
18. Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study.
Bylow K; Hemmerich J; Mohile SG; Stadler WM; Sajid S; Dale W
Urology; 2011 Apr; 77(4):934-40. PubMed ID: 21269665
[TBL] [Abstract][Full Text] [Related]
19. Screening for frailty among older patients with cancer using blood biomarkers of inflammation.
Harneshaug M; Kirkhus L; Benth JŠ; Grønberg BH; Bergh S; Whist JE; Rostoft S; Jordhøy MS
J Geriatr Oncol; 2019 Mar; 10(2):272-278. PubMed ID: 30049582
[TBL] [Abstract][Full Text] [Related]
20. Multidomain Geriatric Screen and Physical Fitness Assessment Identify Prefrailty/Frailty and Potentially Modifiable Risk Factors in Community-Dwelling Older Adults.
Tay LB; Chua MP; Tay EL; Chan HN; Mah SM; Latib A; Wong CQ; Ng YS
Ann Acad Med Singap; 2019 Jun; 48(6):171-180. PubMed ID: 31377761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
